PerkinElmer Receives FDA Clearance for EUROIMMUN Anti-Tissue Transglutaminase ELISA
Serological testing plays critical role in helping diagnose patients with celiac disease WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test system is designed to help clinicians confirm or exclude... Read more